Skip to content
    UO

    University of Cambridge

    Cambridge, United KingdomFounded 2006
    Biotech & Life SciencesManufacturingClimate & Energy

    Cambridge Enterprise, the venture capital arm of the University of Cambridge, focuses on investing in high-impact, high-growth spin-outs and start-ups connected to the University across life sciences, physical sciences, sustainability, and social ventures. Its strategy involves providing early-stage equity investment and support, leveraging the Cambridge ecosystem to accelerate ventures from entrepreneurial academics, students, graduates, and recent alumni.

    33% of their portfolio is in Biotech & Life Sciences. They made 1 investments in the last 12 months. Their most common stage is series-a (67% of deals). Average disclosed round size is $37.8M (across 3 rounds with reported amounts).

    Find people at University of Cambridge on Goldilocks AI

    Portfolio

    3

    Fund Size

    $600M

    Top Stage

    Series A

    Last 12 Mo

    1

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    3 investments
    CompanyRoundAmountDate
    TT-TherapeuticsSeries A$91MNov 2025
    Materials Nexus logoMaterials NexusSeed$2.5MJul 2023
    Riverlane logoRiverlaneSeries A$20M—

    Top Co-Investors

    MD One1 shared
    Draper Esprit1 shared
    Cambridge Innovation Capital1 shared
    Amadeus Capital Partners1 shared
    Tencent Investment1 shared
    F-Prime Capital1 shared

    Last updated: 16 April 2026